Trigeminal neuralgia (TN) is a rare neuropathic facial pain disorder. Two forms of TN, classical TN (CTN) and atypical TN (ATN), are reported and probably have different aetiologies. The aim of the present study was to evaluate the functional integrity of the diffuse noxious inhibitory controls (DNIC) in (1) a group of patients with classical trigeminal neuralgia (CTN), (2) a group of patients with atypical trigeminal neuralgia (ATN), and (3) a group of healthy controls in order to determine if a descending pain modulation deficit could participate in the pathophysiology of TN pain. DNIC responses of 14 CTN patients, 14 ATN patients and 14 healthy controls were obtained by comparing thermode-induced facial heat pain scores before and after activating DNIC. DNIC was triggered using a standard counter-irritation paradigm (i.e., immersion of the arm in painfully cold water). General sensitivity to pain was also evaluated by measuring mechanical pain thresholds over 18 points located outside the trigeminal territory. Healthy participants and CTN patients showed a 21% and 16% reduction in thermode-induced pain following the immersion, respectively (all p-values <.01), whereas ATN patients experienced no change (p = .57). ATN patients also had more tender points (mechanical pain thresholds <4.0 kg) than CTN and healthy controls (all p-values <.05). Taken together, these results suggest that the underlying physiopathology differs between CTN and ATN and that a deficit in descending inhibition may further contribute to the pain experienced by patients with ATN. Ó
Introduction
Trigeminal neuralgia (TN) is a rare neuropathic facial pain disorder affecting the fifth cranial nerve. Two forms of TN, classical TN (CTN) and atypical TN (ATN), are reported [53] . Patients with CTN experience sharp, paroxystic pain lasting from a few seconds to 2 min, whereas ATN patients report (in addition to these pain paroxysms) a more constant and diffuse type of pain which is, clinically, often more difficult to treat [53, 54] . It should be noted that differentiation between CTN and ATN is based on symptom constellation (i.e. presence or absence of constant pain between paroxysms). This categorization should be distinguished from other commonly proposed classifications such as those which divide TN into idiopathic or symptomatic based simply on aetiology [8, 15] .
Even though TN was first described centuries ago, its underlying pathophysiology remains poorly understood [7, 38] . Microvascular compression of the trigeminal nerve continues to be the most proposed cause of TN [30] . However, the latter cannot entirely explain TN as neuroimaging and post-mortem evidence demonstrate that: (1) microvascular compression is absent in many patients with TN [3, 19, 42] , and (2) many people with a microvascular compression do not report facial pain [2, 17, 22] .
Some authors have suggested that a deficit in the functional integrity of endogenous pain modulating responses could contribute to the pain experienced by TN patients [41] . Such a premise comes, for the most part, from the work of Fromm and colleagues [12] who showed, using animal models, that the anticonvulsant drugs that effectively treat TN (carbamazepine, baclofen, phenytoin) increased endogenous pain modulating responses, whereas anticonvulsants that were ineffective in treating TN (phenobarbital) did not affect endogenous pain modulating responses. These observations gave rise to the hypothesis that a failure of inhibitory mechanisms may play an important role in the pathogenesis of TN, a hypothesis that has never been formerly tested.
Endogenous pain modulating deficits as a possible cause of chronic pain is not specific to TN and has in fact been postulated 
